Pancreas cancer trials for early stage disease: Surgeons leading therapeutic cooperative group trials

Rebecca A Snyder; Syed Ahmad; Matthew H G Katz

doi:10.1002/jso.26701

Pancreas cancer trials for early stage disease: Surgeons leading therapeutic cooperative group trials

J Surg Oncol. 2022 Jan;125(1):75-83. doi: 10.1002/jso.26701. Epub 2021 Sep 29.

Authors

Rebecca A Snyder¹, Syed Ahmad², Matthew H G Katz³

Affiliations

¹ Department of Surgery, Brody School of Medicine at East Carolina University, Greenville, North Carolina, USA.
² Department of Surgery, University of Cincinnati Cancer Center, Cincinnati, Ohio, USA.
³ Department of Surgical Oncology, The University of Texas at MD Anderson Cancer Center, Houston, Texas, USA.

PMID: 34586635
DOI: 10.1002/jso.26701

Abstract

Surgeon-led clinical trials have defined the standard of care for locoregional pancreatic cancer to date. The infrastructure and collaborative nature of cooperative oncology groups offer many advantages, such as providing an ideal mechanism through which multidisciplinary pancreatic cancer trials are performed. As key members of the treatment team, surgeons bring experience and expertise to the design of surgical and multidisciplinary trials and are uniquely poised to be leaders of future pancreatic cancer trials.

Keywords: clinical trial; pancreatectomy; pancreatic neoplasms.

Publication types

Editorial

MeSH terms

Clinical Trials as Topic / methods
Clinical Trials as Topic / organization & administration*
Humans
Multicenter Studies as Topic
Neoplasm Staging
Pancreatic Neoplasms / pathology
Pancreatic Neoplasms / surgery*
Patient Care Team
Randomized Controlled Trials as Topic
Surgical Oncology / methods
Surgical Oncology / organization & administration